ALS Research News From The ALS Association's National Office
E-mail us if you would like to sign up to receive Research Updates.
Click here to view information on Clinical Drug Trials
The ALS Association has committed more than $58 million to find effective treatments and a cure for Lou Gehrig’s Disease. Our global research effort has helped increase the number of scientists working on ALS, advanced new discoveries and treatments, and has shed light on the complex genetic and environmental factors involved in ALS.
The ALS Association has made significant research milestones in the fight against ALS, including:
- The groundbreaking discovery of the ALS gene, SOD1, responsible for 20 percent of all inherited ALS cases.
- Discovery of ALS6 in 2009, a new gene responsible for about 5% of all inherited ALS cases.
- The first clinical trial of ISIS-SOD1, a new drug that specifically targets the SOD1 gene
Dr. Lucie Brujin talks about the latest ALS Research
Dr. Bryan Traynor provides information on understanding the genetics of ALS